Tracing cancer in blood via exosomes.
Novel platform technology ExoPheno enabling the discovery and validation of disease-specific exosome subpopulations in biofluids.
Disease-specific exosome targets
Exosomes are the future of routine disease detection
They are circulating snapshots of all cellular activities:
Constantly secreted by all living cells
Protected from enzymatic destruction
Found in all biofluids, including blood
They contain rare molecular information (-omics):
Novel exosome liquid biopsy platform ExoPheno
Exosome Discovery technology:
Method to isolate and sequence the cargo of exosome sub-populations by origin and disease considering two specific surface markers (or more) via proprietary tagging and release
Exosome Validation technology:
Method to trap and identify target exosomes in biofluid via quantum phenomena generated by proprietary nanogap electrodes